[HTML][HTML] Increasing options for the treatment of osteoporosis
S Khosla - The New England journal of medicine, 2009 - ncbi.nlm.nih.gov
More than a decade ago, receptor activator of nuclear factor-κB ligand (RANKL) was
identified as the key molecule mediating osteoclast development, activity, and survival. 1 …
identified as the key molecule mediating osteoclast development, activity, and survival. 1 …
[引用][C] Increasing options for the treatment of osteoporosis
S Khosla - The New England journal of medicine, 2009 - pubmed.ncbi.nlm.nih.gov
Increasing options for the treatment of osteoporosis Increasing options for the treatment of
osteoporosis N Engl J Med. 2009 Aug 20;361(8):818-20. doi: 10.1056/NEJMe0905480. Epub …
osteoporosis N Engl J Med. 2009 Aug 20;361(8):818-20. doi: 10.1056/NEJMe0905480. Epub …
[引用][C] Increasing options for the treatment of osteoporosis
S KHOSLA - N Engl J Med, 2009 - cir.nii.ac.jp
[引用][C] Increasing options for the treatment of osteoporosis
S Khosla - New England Journal of Medicine, 2009 - mayoclinic.elsevierpure.com
Increasing options for the treatment of osteoporosis — Mayo Clinic Skip to main navigation
Skip to search Skip to main content Mayo Clinic Home Mayo Clinic Logo Home Profiles …
Skip to search Skip to main content Mayo Clinic Home Mayo Clinic Logo Home Profiles …
Increasing options for the treatment of osteoporosis.
S Khosla - The New England Journal of Medicine, 2009 - europepmc.org
More than a decade ago, receptor activator of nuclear factor-κB ligand (RANKL) was
identified as the key molecule mediating osteoclast development, activity, and survival. 1 …
identified as the key molecule mediating osteoclast development, activity, and survival. 1 …
[引用][C] Increasing options for the treatment of osteoporosis
S KHOSLA - N. Engl. J. Med., 2009 - cir.nii.ac.jp